RIGEL PHARMACEUTICALS, INC. Other Non-Current Assets
RIGEL PHARMACEUTICALS, INC. (RIGL) had Other Non-Current Assets of $2.94 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-04
- 2026-06-30: Other Assets, Noncurrent $2.94M.
- 2026-03-31: Other Assets, Noncurrent $2.36M.
- 2025-12-31: Other Assets, Noncurrent $1.91M.
- 2025-09-30: Other Assets, Noncurrent $1.17M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $2.94M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $2.36M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $1.91M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $1.17M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $4.18M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $1.52M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $1.53M 10-K · filed 2026-03-03 | $1.44M 10-K · filed 2025-03-04 |
| 2024-09-30 | $4.76M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $4.74M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $4.32M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $3.06M 10-K · filed 2025-03-04 | |
| 2023-09-30 | $4.96M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $541.00K 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $542.00K 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $640.00K 10-K · filed 2024-03-05 | |
| 2022-09-30 | $484.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $403.00K 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $464.00K 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $974.00K 10-K · filed 2023-03-07 | |
| 2021-09-30 | $935.00K 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $840.00K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $818.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $824.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $820.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $653.00K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $661.00K 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $696.00K 10-K · filed 2021-03-02 | |
| 2019-09-30 | $695.00K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $713.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $729.00K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $735.00K 10-K · filed 2020-02-27 | |
| 2018-09-30 | $652.00K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $678.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $754.00K 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $803.00K 10-K · filed 2019-02-28 | |
| 2017-09-30 | $770.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $704.00K 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $730.00K 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $764.00K 10-K · filed 2018-03-06 | |
| 2016-09-30 | $800.00K 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $842.00K 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $1.06M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $1.11M 10-K · filed 2017-03-07 | |
| 2015-09-30 | $1.17M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $1.02M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $1.06M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.09M 10-K · filed 2016-03-08 | |
| 2014-09-30 | $1.41M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $1.46M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $1.48M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $1.53M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $1.59M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $1.64M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $1.70M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $1.76M 10-K · filed 2014-03-04 | |
| 2012-09-30 | $1.83M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $1.88M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $1.93M 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $1.99M 10-K · filed 2013-03-05 | |
| 2011-09-30 | $2.05M 10-Q · filed 2011-11-01 | |
| 2011-06-30 | $2.13M 10-Q · filed 2011-08-02 | |
| 2010-12-31 | $2.23M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |